# Envista to acquire Osteogenics Biomedical business

Envista Holdings Corporation has entered into a definitive agreement to acquire Osteogenics Biomedical Inc, Allotech LLC and OBI Biologics, Inc. The transaction is expected to close in the third quarter of 2022.

- Type: Acquisition
- Announced: 2022-05-17
- Where: United States
- Status: announced
- Products: bone grafting products, regenerative solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [enVista](https://endata.com/companies/56174.md) (acquirer)
- [Osteogenics Biomedical Inc](https://endata.com/companies/62895.md) (target)
- [Allotech LLC](https://endata.com/companies/62896.md) (target)
- [OBI Biologics Inc](https://endata.com/companies/62897.md) (target)

## Sources

- [investors.envistaco.com](https://investors.envistaco.com/2022-05-17-ENVISTA-TO-ACQUIRE-OSTEOGENICS-BIOMEDICAL-BUSINESS), 2022-05-17: "Increasing our capabilities in regenerative solutions is consistent with our intention to digitize, personalize, and democratize oral care."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.